Vaccine Efficacy and Disease Burden Evaluation
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Epidemiology and Vaccination".
Deadline for manuscript submissions: 31 August 2026 | Viewed by 25
Special Issue Editor
Special Issue Information
Dear Colleagues,
Vaccines represent one of the most significant public health interventions for the prevention of infectious diseases. However, their success relies on rigorous evaluations of vaccine efficacy and effectiveness (VE), as well as accurate assessments of disease burden.VE varies by population, context, and pathogen mutations, while disease burden—encompassing incidence, mortality, and economic and societal impacts—guides vaccine prioritization and resource allocation.
We are pleased to invite you to contribute to this Special Issue, entitled “Vaccine Efficacy and Disease Burden Evaluation”. This Special Issue aims to collate high-quality research that advances methodologies and provides insights into VE evaluation and disease burden estimation.
For this Special Issue, original research articles and reviews are welcome to be submitted. Topics of interest include, but are not limited to, the following: research on vaccine efficacy, effectiveness, and safety across populations; studies on immunity persistence and correlates of protection; quantification of disease burden for vaccine-preventable diseases; impact assessments of vaccination programs; and methodological innovations.
We look forward to receiving your contributions.
Dr. Xiaoli Wang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccine efficacy
- vaccine effectiveness
- disease burden
- vaccination programs
- immunogenicity
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
